Cargando…

Therapeutic potential of pomegranate juice-derived nanovesicles in nude mouse benign prostatic hyperplasia (BPH) xenograft model

Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms affect a large percentage of the male population and places a substantial burden on the world health system. Current therapies include 5-alpha reductase inhibitors and alpha-blockers that are only partially effective and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sreekumar, Amritha, Simmons, Matthew N., Lee, Tae Jin, Sharma, Ashok, Saini, Sharanjot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394011/ https://www.ncbi.nlm.nih.gov/pubmed/37528206 http://dx.doi.org/10.1038/s41598-023-39511-w

Ejemplares similares

Role of MicroRNAs in Neuroendocrine Prostate Cancer
por: Sreekumar, Amritha, et al.
Publicado: (2022)

Minimally Invasive Treatment in Benign Prostatic Hyperplasia (BPH)
por: Sciacqua, L. V., et al.
Publicado: (2023)

Role of transcription factors and chromatin modifiers in driving lineage reprogramming in treatment-induced neuroendocrine prostate cancer
por: Sreekumar, Amritha, et al.
Publicado: (2023)

Bladder stone secondary to prostatic urethral lift (PUL) for benign prostatic hyperplasia (BPH)
por: Kang, JiHun
Publicado: (2021)

Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH)
por: Cambio, Angelo J, et al.
Publicado: (2007)

What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)?
por: Foo, Keong Tatt
Publicado: (2019)

Clinical Implications of Residual Urine in Korean Benign Prostatic Hyperplasia (BPH) Patients: A Prognostic Factor for BPH-Related Clinical Events
por: Ko, Young Hwii, et al.
Publicado: (2010)

Early Experience with Laparoscopic Retropubic Simple Prostatectomy in Patients with Voluminous Benign Prostatic Hyperplasia (BPH)
por: Yun, Han Ki, et al.
Publicado: (2010)

Assessing the Influence of Benign Prostatic Hyperplasia (BPH) on Erectile Dysfunction (ED) among patients in Poland
por: Dutkiewicz, Sławomir, et al.
Publicado: (2012)

Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network
por: Hellwege, Jacklyn N., et al.
Publicado: (2019)

Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil
por: Park, Hyun Jun, et al.
Publicado: (2013)

Inflammatory Responses in a Benign Prostatic Hyperplasia Epithelial Cell Line (BPH-1) Infected with Trichomonas vaginalis
por: Kim, Sang-Su, et al.
Publicado: (2016)

Real‐world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spain
por: María Molero, José, et al.
Publicado: (2020)

Serenoa repens and Urtica dioica Fixed Combination: In-Vitro Validation of a Therapy for Benign Prostatic Hyperplasia (BPH)
por: Saponaro, Miriam, et al.
Publicado: (2020)

The single nucleotide polymorphism rs700518 is an independent risk factor for metabolic syndrome and benign prostatic hyperplasia (MetS‐BPH)
por: Chen, Z.P., et al.
Publicado: (2018)

Administration of Caesalpinia bonduc Seed Extracts Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia (BPH) in Male Wistar Rats
por: Sasidharan, Shan, et al.
Publicado: (2022)

1-year cost-utility analysis of prostate artery embolization (PAE) versus transurethral resection of the prostate (TURP) in benign prostatic hyperplasia (BPH)
por: Patel, Nikisha, et al.
Publicado: (2021)

Evaluation of the Antioxidant and Antiangiogenic Activity of a Pomegranate Extract in BPH-1 Prostate Epithelial Cells
por: Consoli, Valeria, et al.
Publicado: (2023)

Androgen Regulated Genes in Human Prostate Xenografts in Mice: Relation to BPH and Prostate Cancer
por: Love, Harold D., et al.
Publicado: (2009)

Selenium in combination with a tomato lipid extract as a therapy for benign prostatic hyperplasia and its alterations in rats with induced BPH
por: Arias‐Chávez, David Julian, et al.
Publicado: (2023)

Prostatic ischemia induces ventral prostatic hyperplasia in the SHR; possible mechanism of development of BPH
por: Saito, Motoaki, et al.
Publicado: (2014)

Variation of Serum PSA Levels in COVID-19 Infected Male Patients with Benign Prostatic Hyperplasia (BPH): A Prospective Cohort Studys
por: Cinislioglu, Ahmet Emre, et al.
Publicado: (2022)

Testosterone inhibits the growth of prostate cancer xenografts in nude mice
por: Song, Weitao, et al.
Publicado: (2017)

Ultrasound-guided SoracteLite™ transperineal laser ablation (TPLA) of the prostate for the treatment of symptomatic benign prostatic hyperplasia (BPH): a prospective single-center experience
por: Laganà, Antonino, et al.
Publicado: (2023)

Long-term survival of stage A prostate carcinoma, atypical hyperplasia/adenosis and BPH.
por: Brawn, P. N., et al.
Publicado: (1994)

Benign Prostatic Hyperplasia
Publicado: (2015)

Pomegranate juice on dental plaque microorganisms
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Transient Hyperphosphatasemia Due to Pomegranate Juice
por: Molina Gutiérrez, Miguel Angel, et al.
Publicado: (2021)

Resveratrol induces apoptosis of benign prostatic hyperplasia epithelial cell line (BPH-1) through p38 MAPK-FOXO3a pathway
por: Li, Chao, et al.
Publicado: (2019)

Prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) in China: results from the China Health and Retirement Longitudinal Study
por: Zhang, Weiyu, et al.
Publicado: (2019)

The EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)
por: Woo, Henry H., et al.
Publicado: (2022)

BPH and prostate cancer risk
por: Miah, Saiful, et al.
Publicado: (2014)

Resveratrol Attenuates the Proliferation of Prostatic Stromal Cells in Benign Prostatic Hyperplasia by Regulating Cell Cycle Progression, Apoptosis, Signaling Pathways, BPH Markers, and NF-κB Activity
por: Jang, Jowon, et al.
Publicado: (2021)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Membrane Transporters in Citrus clementina Fruit Juice-Derived Nanovesicles
por: Stanly, Christopher, et al.
Publicado: (2019)

Patient’s adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy?
por: Cindolo, Luca, et al.
Publicado: (2015)

Priapism, pomegranate juice, and sildenafil: Is there a connection?
por: Senthilkumaran, Subramanian, et al.
Publicado: (2012)

Astaxanthin Inhibits PC-3 Xenograft Prostate Tumor Growth in Nude Mice
por: Ni, Xiaofeng, et al.
Publicado: (2017)

Selective Transurethral Resection of the Prostate Combined with Transurethral Incision of the Bladder Neck for Bladder Outlet Obstruction in Patients with Small Volume Benign Prostate Hyperplasia (BPH): A Prospective Randomized Study
por: Li, Xin, et al.
Publicado: (2013)

A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men
por: Beiraghdar, Fatemeh, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_09g9d1fgs0h70v6rd4lhlfv3ia